Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume
In vivo lung micro-computed tomography (micro-CT) is being increasingly embraced in pulmonary research because it provides longitudinal information on dynamic disease processes in a field in which ex vivo assessment of experimental disease models is still the gold standard. To optimize the quantitat...
Main Authors: | Greetje Vande Velde, Jennifer Poelmans, Ellen De Langhe, Amy Hillen, Jeroen Vanoirbeek, Uwe Himmelreich, Rik J. Lories |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2016-01-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/9/1/91 |
Similar Items
-
A case of bleomycin-induced lung toxicity
by: Cuneyt Tetikkurt, et al.
Published: (2018-11-01) -
Chronic granulomatous ‘Aspergillus lung mass’
by: Kavitha Venkatnarayan, et al.
Published: (2020-09-01) -
Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice
by: Francesca Ruscitti, et al.
Published: (2017-04-01) -
Invasive aspergillosis in cranium and lung: one case report
by: Min CHEN, et al.
Published: (2015-06-01) -
Epidemiology of fungal diseases in Africa: A review of diagnostic drivers
by: Felix Bongomin, et al.
Published: (2021-03-01)